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Natural killer (NK) J cells become activated (reviewed in  1) and proliferate (2, 
3) during the early stages of virus infections, and they have been hypothesized 
to  play a  role  in  natural  resistance  to  viruses  (1).  Although there  have  been 
numerous  demonstrations of NK  cell-mediated lysis of virus-infected cells  in 
vitro (reviewed in 4), there has been no definitive demonstration of an antiviral 
role for NK cells in vivo. Data in support of this hypothesis have been subject to 
other interpretations. The main approach has been to correlate susceptibility to 
virus  infection with  NK cell  activity, which  can be  determined  genetically or 
manipulated experimentally. 
The  best  evidence,  using  this  approach,  has  been  obtained  in  the  case  of 
murine  cytomegalovirus (MCMV)  infection.  Studies  have  shown  that  genetic 
resistance to MCMV correlates with NK cell activity in mice (5, 6). Homozygous 
beige mice, which have a  defect in  NK cell-mediated cytotoxicity, are  highly 
susceptible to MCMV, and resistance, along with NK cell activity, is restored to 
beige mice by transfers of bone marrow cells from normal mice (6).  Newborn 
mice, which have low NK cell activity, are highly sensitive to MCMV (7), as are 
adult mice  whose  NK cell activity has been  depleted by nonspecific immuno- 
suppression  (8,  9).  Recently (10,  1 1)  we  have  shown that  antiserum  to asialo 
GMi,  a  reagent  which,  rather  selectively, eliminates NK  cell  activity in  mice, 
greatly enhances MCMV growth and pathogenesis. Biological response modifiers 
that activate NK cells in vivo, in the absence of interferon (IFN), render mice 
more resistant to MCMV; this resistance is abrogated by antiserum to asialo GM~ 
(12). 
The above experiments provide a  strong argument for a  role of NK cells in 
resistance to MCMV, but they are not definitive. For example, beige mice have 
a  biochemical defect that affects functions other than NK cells (13), and asialo 
GMj  is  a  common  molecule  found  on  several  cell  types  (14,  15).  To  more 
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definitively assess  the  role  of NK cells  in  virus  infections,  we  have  developed 
cellular  adoptive  transfer  methods  that  identify  the  effector  cells  mediating 
natural resistance. These methods are used to manipulate infections with MCMV 
and  with  lymphocytic choriomeningitis  virus (LCMV),  which  appears  to  resist 
NK cells. LCMV synthesis is normal in beige mice (16) and in mice treated with 
anti-asialo GMI (10). We report here that the transfer of only those populations 
of cells containing NK cell activity can protect suckling mice against MCMV, but 
leave them unprotected from LCMV. Furthermore, adoptive transfer of cloned 
NK  cells,  but  not  T  cells,  provides  resistance  to  MCMV,  but  not  to  LCMV. 
These data provide compelling evidence in favor of a role for NK cells in at least 
one (MCMV) viral infection. 
Materials and  Methods 
Animals.  C57BL/6 and BALB/c mice were purchased from The Jackson Laboratories, 
Bar Harbor, ME, and bred in our facility. SWR/J athymic nude mice were a gift from Dr. 
Aldo  Rossini,  University  of  Massachusetts  Medical  Center.  Donor  mice  for adoptive 
transfer studies were 4-8 wk old, unless otherwise noted. 
Cells.  YAC-1  cells were derived from a  Moloney leukemia virus-induced lymphoma 
from an A]Sn mouse, and were maintained in RPMI 1640 medium (Gibco Laboratories, 
Grand Island,  NY) supplemented with antibiotics, glutamine, and  10% heat-inactivated 
fetal bovine serum (FBS) (M. A. Bioproducts, Walkersville, MD). Mouse embryo fibroblasts 
(MEF) were obtained as described (17) from C57BL]6 embryos. Vero cells are a contin- 
uous monkey kidney cell line.  L-929 is a  continuous liver cell line derived from C3H 
mice. These cells were maintained in minimal essential medium (MEM) (Gibco Labora- 
tories) with the same additives as listed above. Baby hamster kidney 21/13S  cells  were 
maintained in  Dulbecco's modified Eagle's medium (Gibco Laboratories) supplemented 
with 10% tryptose phosphate broth and the same additives as listed above. 
Viruses.  The  Smith  strain  of MCMV  was  obtained  from  Dr. John  Nedrud,  Case 
Western  Reserve University School  of Medicine,  Cleveland,  OH (18).  Salivary glands 
from BALB/c mice inoculated 2-3 wk previously with 104 plaque-forming units (PFU) of 
MCMV were homogenized in a  10% suspension, and cleared by centrifugation. Aliquots 
were stored at -70°C in  10% dimethylsulfoxide. The LCMV used in these studies was 
the Armstrong strain, which was grown in BHK cells (19). The Indiana strain of vesicular 
stomatitis virus (VSV) was used in the IFN assays. 
Cytotoxicity  Assay.  Assay medium was  RPMI  1640  supplemented  with  0.1  M  Hepes 
(Sigma Chemical Co.,  St.  Louis,  MO),  10%  FBS, glutamine, and antibiotics. The assay 
was  performed as  described  (19).  Briefly, target  cells,  labeled  with  100  #Ci  [SICr]so- 
dium chromate (New England Nuclear, Boston, MA) for 1 h at 37°C, were washed and 
mixed with various numbers of effector cells in round-bottomed microtiter wells at  104 
target ceils/well. For spontaneous release determinations, medium was added to the wells, 
and  for maximum release  determinations,  1%  Nonidet  P-40  was added.  Plates  were 
incubated for 4-16 h at 37°C in a humidified atmosphere of 5% CO2 and 95% air. At 
the end of the incubation, plates were centrifuged at 200 g for 5 rain, and 0.1  ml of the 
supernatant  was  collected  and  counted  for radioactivity in  a  Beckman  Gamma 5500 
counter  (Beckman  Instruments,  Inc.,  Palo  Alto,  CA).  Data  are  expressed as  percent 
specific release:  100  ×  [(cpm experimental -  cpm spontaneous)/(cpm maximum -  cpm 
spontaneous)]. Spontaneous release of radioactivity was 10-20%. Standard deviations of 
quadruplicate replica samples were <10% of mean, and were not listed in the tables. 
Virus Titration.  Spleen and liver virus titers were determined by using a  10% homog- 
enate of tissue taken from individual mice. The number of PFU was determined by plaque 
assay using  MEF and Vero cells for MCMV and  LCMV, respectively. Virus titers are 
reported per spleen and per gram of liver. Results are expressed as the geometric mean 
titer,  i.e.,  the  arithmetic  averages  of the  logs  of titers  from  four  separately  titrated 
individual animals, plus or minus the standard error of the mean (SEM).  The P  values 42  NATURAL  KII.LER CELLS  MEDIATE ANTIVIRAL EFFECTS  IN  VIVO 
represent the significance of the differences of the means between the designated sample 
and the appropriate control, and were calculated using a Student's t test. 
Antisera.  Rabbit antiserum against asialo GM1 was purchased from Wako Chemicals, 
USA, Inc., Dallas, TX. This antiserum has previously been shown to selectively deplete 
NK cell activity in vivo and in vitro (14,  15, 20). To deplete NK cell activity in vivo, anti- 
asialo GMj was diluted  1:10 in RPMI medium and given intravenously in a volume of 0.2 
ml,  4-6  h  before challenge with  virus.  In adoptive transfer  experiments,  donor spleen 
cells from control mice treated with anti-asialo GM1  were used  18-24 h  after antibody 
treatment.  Monoclonal anti-Thy-l.2 antibody (mAb) was provided by Dr. Edward Clark, 
University of Washington, Seattle, WA and used at a final dilution of 1:900. Anti-Ly-5.1 
(clone M 1/89.18) and anti-Ia (clone M5/114) mAb, gifts from Dr. Eric Martz, University 
of Massachusetts,  Amherst,  MA (21),  were  used  at  a  final  dilution  of 1:40 and  1:100, 
respectively. The antiserum to NK  1.2 was a gift from Dr.  Robert Burton (22), and was 
used at a final dilution of 1:40. For in vitro treatment of spleen cells, 2.5-4.0 x  108 spleen 
leukocytes were suspended in 2.5 ml RPMI containing antibody, and incubated for 20- 
30  min at  room  temperature  with  occasional agitation.  250 #1 of guinea pig serum  (a 
source of complement; C') was added, and the incubation was continued at 37°C for an 
additional  45  rain.  The cells  were  washed  twice and  resuspended  in  RPMI  for use  in 
adoptive  transfer  and  cytotoxicity assays.  The  cell  numbers  transferred  refer  to  the 
number of viable cells before the antibody and C' treatment. 
Cloned  NK  Cells.  NK1B6B10,  a  clone  of interleukin  2  (IL-2)-dependent  NK  cells 
derived from C57BL/6 mice, was maintained as described (23), with a few modifications. 
Growth medium was RPMI  1640 supplemented with 2 mM L-glutamine,  1 mM sodium 
pyruvate,  0.1  mM  MEM nonessential  amino acids (Gibco Laboratories),  5  x  10  -5 M  2- 
mercaptoethanol, 50 U/ml penicillin and streptomycin,  100 #g/ml gentamycin, 5% FBS, 
and  24%  supernatant  derived  from concanavalin A-stimulated  mouse spleen  cells as a 
source of IL-2. For use in experiments, cells growing in 25- or 75-cm  2 flasks were washed, 
and adherent  cells were removed with  trypsin-EDTA (Gibco Laboratories) and diluted 
1:4 in growth medium. This suspension was then incubated at 37 °C for 1 h in a conical 
test tube, with occasional agitation. Cells were then counted, pelleted at 200 g for 5 min, 
and  resuspended  in  RPMI  for  use  in  cytotoxicity assays and  adoptive  transfers.  As a 
control, a  C57BL/6-derived cytotoxic T  cell  line (CTLL-2 clone  15  H) (24),  routinely 
used as indicator cells in IL-2 bioassays, were also used. 
Adoptive  Transfers.  Recipients were C57BL/6 suckling mice 3-5 d old. Before use in 
experiments,  mice from several litters were pooled and randomly reassigned to lactating 
mothers. Groups of four to nine mice were given an injection of cloned NK cells or mouse 
spleen cells treated in various ways. We delivered 0.1  ml i.p.  using a  1-ml syringe and a 
30 gauge needle. The next day, mice were challenged with 6 x  l0 s PFU of MCMV or 8 
X  103 PFU of LCMV in a volume of 0.1  ml i.p. Mice were monitored daily for survival. 
Some were killed  3  d  later,  and their spleens  removed and  used for virus titration.  In 
some experiments,  using the cloned NK cells (23),  4-wk-old C57BL/6 mice were given 
four weekly doses of 200 rad 3" radiation from a 6°Co source. 5 wk after the last dose, the 
mice were given 10 ~1 anti-asialo GM, intravenously, followed 2 d later by 4 x  106 cloned 
NK  cells,  half given  intraperitoneally,  the  other  half given  intravenously.  6  d  later, 
intraperitoneal and intravenous injections were again administered, each consisting of 106 
cloned NK cells.  10 d after the last injection, groups of five mice were challenged with an 
intraperitoneal  injection of 104  PFU  of MCMV.  Controls consisted of irradiated,  anti- 
asialo GM~-treated mice that had not received injections of NK cells.  3 d  later, the mice 
were sacrificed, and their spleens and livers were titrated for virus. 
Interferon  Assay,  Blood was collected in heparinized Natelson tubes.  Mice were anes- 
thetized with ether before being bled from the retroorbital sinus. Plasma was obtained by 
centrifugation. Plasma were titrated by twofold serial dilution in a 96-well, flat-bottomed 
microtiter plate to which L-929 cells were added at 3 ×  104 cells/well.  18-24 h later, the 
wells were challenged with  100 TCID~0 U of VSV. IFN titers were expressed as the log~ 
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Results are expressed as the geometric mean titers of separate animals titrated for IFN 
individually + SEM. 
Centrifugal Elutriation.  Size separation of cells was accomplished using a Beckman JE- 
6B centrifuge (2).  -109 spleen leukocytes were treated with deoxyribonuclease (Sigma 
Chemical Co.) to prevent clumping. These cells were then loaded into a rotor that was 
spinning at 3,200 rpm at 5°C. The rate of flow of elution medium (Hanks' balanced salt 
solution, 1.5% calf serum) was  15, 22, 28, and 46 ml/min, corresponding to fractions 1- 
4. Cell recovery was ~65%. Fraction 2 was used as a source of purified lymphocytes. 
Enrichment of NK Cells.  Spleen leukocytes (1.6 x  109) were passed through nylon wool 
columns and further separated on discontinuous Percoll gradients according to the method 
of Kumagai et al. (25), with some modifications. One part 10X phosphate-buffered saline 
and one part FBS were added to eight parts  Percoll to obtain  80%  Percoll. This was 
further diluted using RPMI  1640 containing 10% FBS. 6-7 X 107 cells were suspended 
in 3 ml 64% Percoli and pipetted into a 15 ml conical test tube. 3 ml of 59, 50, and 37% 
Percoll were sequentially layered on top of the cell suspension. Centrifugation was at 300 
g and 20 °C for 45 min. Cells at the very top of the gradient were discarded. Cells floating 
atop the 59 and  50%  Percoll bands were pooled, and those atop the 63%  band were 
pooled with  those in  the  pellet.  The latter cells  were  found to be devoid of NK cell 
activity, and were used in adoptive transfer experiments. The cells from the 59 and 50% 
bands were pooled and further purified on a second Percoll gradient. 6  x  10 7 of these 
cells were suspended in 6 ml 59.5% Percoll, and 3 ml of 55.0 and 37.0% Percoli were 
sequentially layered on top of the cell suspension. Centrifugation was carried out as before, 
and cells floating atop the 55.0% Percoll band were washed and used in adoptive transfer 
studies, since they were found to be enriched for NK cell activity. 
Results 
Protection  Against Lethal MCMV by Adoptive Transfer of Adult Spleen  Leukocytes 
or Lymphocytes.  Suckling mice have  low  NK  cell activity and  are  much  more 
susceptible to MCMV  infection than  adult mice (7). Selgrade and Osborn (17) 
have shown that adult spleen leukocytes can protect suckling mice against lethal 
MCMV  infection.  Fig.  1A  shows  that  adoptive transfer of 5  X  107  leukocytes 
from  4-8-wk-old  mice  significantly  prolonged  the  survival  of  mice  lethally 
infected with MCMV, but that transfer of 1.7 x  107 or fewer leukocytes did not. 
Fig.  1B  shows  that  5  x  107  spleen  leukocytes  from  5-wk-old  donors  were 
significantly more effective than  those from  17-d-old donors in prolonging the 
lives of MCMV-infected suckling mice. To further define which population of 
leukocytes was  providing protection,  we obtained purified spleen  lymphocytes 
by performing centrifugal elutriation on unseparated spleen cells. Fraction 2 was 
routinely found to contain ~98% lymphocytes, and <1% of the cells were capable 
of phagocytizing yeast particles, indicating minimal  contamination with macro- 
phages.  Fig.  1 C shows that these purified lymphocytes were more capable than 
unfractionated  leukocytes  in  prolonging  survival.  These  experiments  demon- 
strate  that  protection can  be mediated by a  population  of spleen lymphocytes 
present in adult, but not  17-d-old mice. 
T  Cell  Depletion  Does Not Affect Protective  Capacity.  Spleen  leukocytes were 
depleted of T  cells by treatment with anti-Thy-l.2 mAb and C', then adoptively 
transferred into recipient suckling mice. This treatment kills ~35% of the cells, 
eliminates LCMV-specific cytotoxic T  cell activity of sensitized spleen cells, but 
has  little  effect on  NK  cell  activity  (19).  Fig.  1D  shows  that  T  cell-depleted 
spleen leukocytes were just as protective as those treated with C'  only, leading 
us to conclude that protection occurs in the absence of adoptively transferred T 44  NATURAL KILLER  CELLS  MEDIATE ANT1VIRAL  EFFECTS  IN  VIVO 
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FIGURE  1.  Effect of adoptive transfer of various spleen cell populations on survival of MCMV- 
infected suckling mice. Suckling mice 3-5 d old were (unless otherwise indicated) given 5 x 
107  spleen  cells (which were  left  untreated or fractionated  as described  in Materials and 
Methods), or medium alone. This intraperitoneal injection was followed 24 h later by 6 x  l0  s 
PFU of MCMV, also given intraperitoneally. Mice were monitored for survival for 20 d. (.4) 
Various numbers of adult spleen leukocytes were transferred. Five mice per group. (B) Spleen 
leukocytes from  suckling and weanling mice were used as donor cells. Five to six mice per 
group. (C) Spleen leukocytes or size-separated lymphocytes were used as donor cells. Six to 
seven mice per group. (D) Spleen leukocytes treated with C' or anti-Thy-1.2  and C' were used 
as donor cells. Seven mice per group. (E) Spleen leukocytes from control or anti-asialo GM]- 
treated mice were used as donor cells. Seven to nine mice per group.  (F) Spleen leukocytes 
treated with C', anti-Ly-5 and C', or anti-la and C' were used as donor cells. Six mice per 
group. 
cells.  Another  line of evidence indicating that protection can occur without T 
cells  is  shown  in  Fig.  2.  Athymic  nude  mice  were  either  left  untreated  or 
selectively depleted of NK cell activity by injection with anti-asialo GM,. 4-6 h 
later,  the  mice  were  challenged  with  MCMV.  The  data  show  that  MCMV- 
infected NK cell-depleted mice had five to six times more liver virus and two to 
three times more spleen virus than control MCMV-infected mice. This provides 
evidence that T  cells are not required for the anti-asialo GM~-mediated exac- 
erbation of MCMV infection. BUKOWSKI  ET  AL.  45 
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FIGURE 2.  NK  cell  depletion  lowers resistance to  MCMV  in  nude  mice.  SWR/J  athymic 
nude mice were left untreated, or given 20 ~1 anti-asialo GM] intravenously. 4-6 h later, these 
mice were challenged with 5 x  10"PFU of MCMV intraperitoneally. 3 d later, the mice were 
killed, and their organs were titrated for MCMV, their spleens assayed for NK cell activity, 
and their plasma titrated for 1FN. Four mice per group. 
Depletion of  NK Cells Results in Loss of  Protection.  Spleen ieukocytes from adult 
mice, either untreated, or NK cell-depleted (by injection with anti-asialo GM] 
18-24 h earlier) were adoptively transferred into suckling mice. This treatment 
reduced NK cell activity from 21  to -2.7%.  Fig.  1E shows that the cells from 
mice depleted of NK activity by anti-asialo GMI failed to prevent death of mice 
infected with MCMV, whereas control leukocytes totally prevented death. Treat- 
ment of leukocytes with anti-Ly-5 mAb and C' reduced NK cell activity from 20 
to 8.6%, and eliminated the protection. But treatment with anti-Ia mAb and C', 
which killed 40% of spleen leukocytes but did not deplete NK cell activity, had 
no effect on  the ability  of spleen  cells to  protect (Fig.  1 F).  This  shows that 
leukocytes depleted of B cells and other Ia-bearing cells can still protect against 
lethal infection. 
Reduction of Spleen Virus Titers by Adoptive Transfer of NK Cell-enriched Leuko- 
cytes.  Since previous studies (11) showed that increased survival correlates with 
lower spleen MCMV titers, we titrated the spleens of MCMV-infected suckling 
mice 3 d postinfection. The data in Table I, A-D, show that those mice receiving 
control adult spleen leukocytes had significantly lower spleen MCMV titers than 
those receiving no cells. Transfer of nylon wool-passed cells also reduced MCMV 
titers in recipients, confirming data in Fig.  1, which show that cells depleted of 
B cells and macrophages can protect against MCMV (Table IA). Kumagai et al. 
(25) have shown that large granular lymphocytes containing NK activity can be 
purified on gradients of Percoll. With a  similar technique, nylon wool-passed 
leukocytes were subfractionated in Percoll gradients to enrich for, or to deplete 
NK cells (Table IB). The experiment depicted in Fig.  1A suggested that  1.7  x 
107 control spleen cells did not enhance survival, but that three times as many 
of these cells did. Table IB shows that  1.7 x  107 control spleen cells resulted in 
only a three- to fivefold reduction in MCMV titers in the recipient spleens, but 
that the same number of cells, enriched threefold for NK cell activity (in low 
density fractions after Percoll purification) resulted in a  (-30-fold) decrease in 46  NATURAL  KII.LER  CELLS  MEDIATE  ANTIVIRAL  EFFECTS  IN  VIVO 
TABLE  1 
Reduction of MCMV Titers by Adoptive Transfer of CeU Populations Containing NK Cell 
Activity* 
Percent NK 
Exp.  E/T*  cell lysis  t by  Number of cells used, and  logl0 PFU of 
donor cells  treatment  MCMV per spleen 
A  Medium alone  4.1  -  0.1 
ND  5  x  107 Control spleen  2.5 --- 0.2 II 
5  x  107  Nylon wool-passed  2.3 -+ 0.2 ~ 
spleen 
Medium alone  2.9 +  0.1 
0.2  1.7 X  107  Percoll, high  3.1  +_ 0.1 
density 
39.0  1.7 x  107 Percoll,  low den-  1.5 _  0.2 ~ 
sity 
14.0  1.7 x  107 Control spleen  2.4 +  0.1 
14.0  5.0 x  107 Control spleen  1.4 +  0.2 
25 
Medium alone  4.1  _+ 0.1 
29.0  5  ×  107 Control spleen  2.7 +  0.1 
24.0  5  x  107 Control spleen +  2.8 +- 0.1 
C' 
8.5  5  ×  107 Control spleen +  3.7 _  0.1"* 
anti-NK  1.2 -  C' 
50 
Medium alone  4.6 ___ 0.1 
23.  5  x  107 Control spleen  3.2 +  0.1 
3.3  5  x  107 Anti-AGMj spleen  4.1  --- 0.15* 
ND  5  ×  105 Cloned NK cells  1.9 +  0.1 
20 
Medium alone  4.5 +  0.1 
40.0  5  ×  10  ~ Cloned NK cells  1.8 _  0.2 • 
1.2  5  x  105 Cloned T  cells  4.4 +  0.1 
* Groups of four suckling mice were  given intraperitoneal  injections of cells treated  as indicated 
above, or RPM 1 1640 medium. The next day, they were challenged with 6 ×  103 PFU of MCMV. 
3  d  later the mice were  killed and their spleens titrated for MCMV. (Exp. A) Donor spleen cells 
were  either  left  untreated  or  passed over  nylon  wool  columns, as  described  in  Materials  and 
Methods. (B)  Donor spleen cells were  left untreated, or fractionated by nylon wool passage and 
Percoll density gradient centrifugation, as described in Materials and Methods. (C) Donor spleen 
cells were  left untreated,  treated  with  C',  or treated  with anti-NK  1.2 and C',  as described  in 
Materials and  Methods.  (D)  Donor  spleen cells  were  from  control  mice  or  mice  treated  24  h 
earlier with anti-asialo GMI.  Donor  NK cells were  the cloned  NK1B6B10  line. (E)  Donor  NK 
cells were the cloned NK1B6B10 line, and T  cells were CTLL-2 clone 15 H. 
* Effector/target ratio. 
Percent NK cell lysis refers to percent specific release against YAC-I  targets at a given E/T ratio, 
as described in Materials and Methods. 
I p  <  0.001  as compared with medium. 
P  <  0.01  as compared with  1.7 x  107 control spleen cells. 
** P  <  0.01  as compared with control spleen +  C'. 
P  <  0.01  as compared with control spleen. 
~P  <  0.001  as compared with cloned T  cells. BUKOWSKI  ET  AL.  47 
MCMV titers. Mice receiving an equal number of Percoll-separated high density 
cells devoid of NK  cell  activity were not protected at  all.  Thus,  nylon  wool- 
passed,  Percoll gradient-fractionated  spleen cells enriched  for NK cell activity 
have an enhanced capacity to reduce virus titers, as compared with control spleen 
leukocytes, or those devoid of NK cell activity. 
Failure of  NK Cell-depleted Leukocytes to Reduce Virus Titers.  Immunochemical 
depletion  of NK  cell  activity  from  the  donor  spleen  before adoptive  transfer 
drastically reduced the ability of the spleen cells to inhibit  MCMV synthesis in 
recipients. Transfer of adult spleen cells treated with anti-NK  1.2 and C' (Table 
IC) or spleen  cells from anti-asialo  GM]-treated  mice (Table  ID) resulted  in 
recipient  spleen  MCMV titers that  were nearly  10 times higher  than  those of 
recipients receiving control adult spleen cells. 
Cloned NK Cells Provide Protection Against MCMV.  To further strengthen the 
evidence that NK cells are mediating antiviral effects in vivo, we used the cloned 
IL-2-dependent  NK  cell  line  NK1B6B10  as  donor  cells  in  adoptive  transfer 
experiments. The data in Table I, D and E, show that these cells were extremely 
effective in  reducing  MCMV titers,  as mice receiving the cloned NK cells had 
~500-fold less MCMV in their spleens than did mice receiving an IL-2-dependent 
T  cell clone (CTLL-2 clone  15 H, also derived from C57BL/6 mice; 24) or no 
cells at all. On a cell/cell basis, the NK cell clone was >100 times more effective 
than adult ieukocytes, as 5  ×  105 of the cloned cells were far more effective at 
reducing MCMV titers than  were 5 ×  107 leukocytes. These experiments show 
that an NK cell clone, by itself, can limit MCMV replication, and that an irrelevant 
T  cell clone cannot. Cloned NK cells were also capable of enhancing the survival 
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FIGURE 3.  Cloned NK cells enhance survival of MCMV-infected suckling mice. Cloned NK 
cells were adoptively transferred into recipient suckling mice and then challenged 24 h later 
with 6  ×  10 s PFU of MCMV. Control mice received no cells.  Mice were observed 20 d  for 
mortality. Eight mice per group. 48  NATURAL  KILLER  CELLS  MEDIATE  ANT1VIRAL  EFFECTS  IN  V1VO 
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FIGURE 4.  Cloned NK cells inhibit MCMV replication in adult mice. Adult C57BL/6 mice 
were irradiated and left untreated or injected with cloned NK cells, as described in Materials 
and Methods. These mice were then challenged with  104 PFU of MCMV intraperitoneally, 
and killed 3 d later. Spleens and livers were titrated for MCMV, spleens were assayed for NK 
cell activity, and plasma was titrated for IFN. Five mice per group. 
TABLE  II 
Adoptive  Transfer of Cell Populations Containing NK Cell Activity 
Has No Effect on LCMV Titers* 
Exp.  Number of cells used, and  Iog~0 PFU of 
treatment  LCMV per spleen 
A  Medium alone  4.7 + 0.1 
5 x  10 7 Control spleen  4.4 __. 0.1 * 
B  Medium alone  4.7 + 0.1 
5 ×  105 Cloned NK cells  4.7 +- 0.2* 
* Groups of four suckling mice were given intraperitoneal injections of 
control spleen cells, the NK cell clone NK1B6B10, or RPM1 medium. 
The next day, they were challenged with 8 ×  l0  s PFU of LCMV.  3 d 
later, the mice were sacrificed and their spleens were titrated for LCMV. 
* Not significantly different from medium. 
of MCMV-infected  mice,  since  75%  of mice  receiving only  3  X  100  NK  cells 
survived, compared  with none of the control mice (Fig. 3). 
To  test whether  the  NK  cell clone could protect adult mice from  MCMV,  6 
wk-old  mice  were  irradiated  four  times  with  200  rad  at  weekly  intervals  to 
deplete  NK  cell  activity,  then  given  injections  of  the  cloned  NK  cells.  The 
reconstituted  recipients had elevated spleen  NK cell activity and  reduced  virus 
titers in  their spleens and  livers (Fig.  4).  IFN  levels were  slightly higher  in  the 
unreconstituted  mice,  which  synthesized  more  virus.  The  experiments  provide 
evidence that NK cells can mediate antiviral effects in adult as well as in suckling 
mice. 
Adoptive Transfer of NK Cells Has No Effect on LCMV Titers.  Previous evidence 
(10,  16)  had  suggested  that  NK  cells  do  not  play  a  role  in  limiting  LCMV BUKOWSK1  ET  AL.  49 
synthesis during acute or persistent infection. To test this hypothesis using our 
adoptive transfer system, we transferred either 5 ×  107 adult spleen cells or 5 × 
10 "~ cloned NK cells into suckling mice and challenged them the next day with 
LCMV.  Table  II, A  and B  shows that  the  transfer had no  effect on  LCMV 
synthesis in the spleens of recipient mice. Thus, adoptive transfer of NK cells 
markedly inhibited MCMV synthesis but had no effect on LCMV synthesis. 
Discussion 
The results presented in this paper provide compelling evidence that NK cells 
play a  major role in  limiting MCMV synthesis and MCMV-induced mortality. 
The  phenotype  of  the  protective  cell  population  is  that  of a  nylon  wool- 
nonadherent, asialo GM1 +, NK 1.2 ÷, Ly-5  +, Thy-l-, Ia-, low density lymphocyte. 
This describes an NK cell (reviewed in 26). In each case, thepresence or absence 
of NK  cell  activity  in  the  adoptively  transferred  population  correlated with 
resistance and sensitivity to MCMV, respectively. 
Because  data  for  survival  curves must  be  accumulated over  2-3  wk,  it  is 
possible that during that time subpopulations of spleen cells could differentiate 
and subsequently provide resistance,  making the results difficult to interpret. 
However, in  many experiments, suckling mice receiving NK cells were larger 
and weighed more than mice not receiving NK cells, even 3 d postinfection (data 
not shown). Previous studies (11) with anti-asialo GM1 suggested that NK cells 
could mediate their antiviral effects up to 3 d  postinfection, but not at 6-9 d. 
The  present  experiments,  involving  titration  of  MCMV  in  the  spleen  3  d 
postinfection, confirm this result and indicate that it is not due to differentiation 
and sensitization of T  cells over the long time period. T  cells are reported to 
mediate antiviral effects 6-30 d postinfection (27). Further arguments against a 
role for T  cells early in infection include the fact that NK cell depletion lowers 
the resistance of athymic nude mice to MCMV infection (Fig. 2), and the lack of 
effect of T  cell depletion by antiserum to Thy-1.2 plus C' on the antiviral action 
of transferred spleen cells (Fig.  1 D). Whereas some NK cells express some Thy- 
1  antigen  (26),  the  concentrations  of antiserum  and  C'  used  here  deplete 
cytotoxic T  lymphocyte activity, but have little effect on endogenous NK cell 
activity (19). 
Selgrade and  Osborn  (17) concluded that either unstimulated macrophage- 
depleted  spleen  leukocytes or  thioglycollate-induced peritoneal  macrophages 
could enhance survival of MCMV-infected suckling mice. However, the nature 
of the spleen leukocyte was not identified. Whether unstimulated macrophages 
could provide resistance to MCMV remains at issue, as the macrophages used in 
those  studies  were  thioglycollate-induced. Our  studies  were  not  designed  to 
answer this question, but, nevertheless, show that spleen cells depleted of mac- 
rophages  by nylon wool  passage  or  size  separation  retained the capability to 
provide protection. Thus, adoptive transfer of macrophages is not essential to 
the transfer of resistance. Antibodies that leave macrophage function intact, such 
as anti-asialo GM1, anti-Ly-5, and anti-NK  1.2, eliminate both NK cell activity 
and protection against MCMV. 
There has been little evidence to implicate neutrophils in resistance to MCMV. 
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with >98%  purity are quite capable of mediating resistance. Neutralizing anti- 
body can  be  detected as  early as  3  d  postinfection in  adult  mice, and could 
possibly mediate protection (28), but our experiments show that depletion of B 
cells, by treatment with anti-Ia and C', or by nylon wool passage, did not remove 
the protective capacity of spleen cells, indicating that adoptive transfer of B cells 
was not required for protection. 
The survival curves indicate that  5  x  107  adult spleen cells could prolong 
survival of MCMV-infected mice, but that threefold fewer cells could not. If the 
protection were mediated by NK cells, then threefold fewer spleen cells with 
three times as much NK cell activity should protect. This prediction was sup- 
ported by our data;  1.7 x  107 unfractionated spleen cells or the same number of 
NK cell-deficient spleen cells did not fully protect, while 1.7  x  107 spleen cells, 
enriched threefold for NK cell activity, significantly reduced MCMV titers. 
Previous work (29) using an IL-2-dependent cloned NK cell line showed that 
these cells were capable  of mediating resistance to  tumor implants and  bone 
marrow transplants. These cells have the phenotype: asiaio GMI +, NK 1.2 +, Thy- 
1  +,  Ly-l-,  Ly-2-,  and  are  capable  of  mediating  in  vitro  lysis  against  NK 
cell-sensitive  YAC-1  tumor  cells  (23).  Our  results  show  that  these  cells  are 
capable of providing protection against MCMV, but not LCMV.  In contrast, a 
cloned T  cell  line also derived from C57BL/6  mice provided  no protection, 
indicating that cloned lymphoid cells in general do not necessarily protect. The 
data  obtained  with  cloned  NK  cells  also  indicate  that  no  other  adoptively 
transferred cell population was needed for protection. NK cells either directly 
mediated resistance or were solely responsible for triggering recipient defense 
mechanisms. 
We conclude from our results that NK cells can provide protection against at 
least one (MCMV) but not all  (LCMV) virus infections. There are other data 
consistent with the concept that NK cells play a role in murine infections with 
herpes simplex virus (30), mouse hepatitis virus (10, 31), Friend leukemia virus 
(32), and vaccinia virus (10). There also is evidence consistent with the hypothesis 
that  NK  cells may inhibit  outgrowth of tumor cells persistently infected with 
measles or VSV (33). Evidence against a role for NK cells has been provided for 
LCMV (10,  16) and Sindbis virus (34). Why NK cells should play a role in some 
but not all  virus infections is not known, but our recently obtained evidence  2 
shows that the NK cell system may have an ability to selectively lyse cells infected 
with MCMV, an NK-sensitive virus, but not LCMV, an NK-resistant virus. 
Summary 
We carried out adoptive transfer studies to determine the role of natural killer 
(NK) cells in  resistance to  murine cytomegalovirus (MCMV) and  lymphocytic 
choriomeningitis Virus (LCMV). We transferred leukocytes from adult mice into 
suckling mice 1 d before injecting them with virus. Resistance was measured by 
enhancement of survival and reduction of virus multiplication in the spleens of 
recipient  mice.  The  phenotype  of the  cell  population  capable  of mediating 
2 Bukowski, J. F., and R.  M. Welsh.  1984.  Susceptibility of virus-infected targets to natural  killer 
cell-mediated  lysis  in  vitro  correlates  with  natural  killer  cell-mediated  antiviral  effects in  vivo. 
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resistance  to  MCMV  was that  of a  nylon  wool-nonadherent,  asialo GM1 +,  NK 
1.2 ÷, Ly-5  +, Thy-l-,  Ia-, low density lymphocyte; this is the phenotype of an NK 
cell.  Cloned  NK cells,  but not cloned T  cells, provided resistance to MCMV  in 
suckling mice. Cloned  NK cells also provided resistance to MCMV in irradiated 
adult mice, and antibody to asialo GM1, which depletes NK cell activity in vivo, 
enhanced the synthesis of MCMV in athymic nude mice. Neither adult leukocytes 
nor cloned NK cells influenced  LCMV synthesis in suckling mice. We conclude 
that a  general property of NK cells may be to provide natural resistance to virus 
infections, and that NK cells can protect mice from MCMV but not from LCMV. 
Received for publication  16 August  1984 and in revised form 9 October  1984. 
References 
1.  Welsh, R. M.  1978. Mouse natural killer cells: induction, specificity, and function.J. 
Immunol.  121:1631. 
2.  Biron, C. A., and R. M. Welsh. 1982. Blastogenesis of natural killer cells during viral 
infection in vivo.J. Immunol.  129:2788. 
3.  Biron, C. A., L. R. Turgiss, and R. M. Welsh.  1983. Increase in NK cell number and 
turnover rate during acute viral infection. J. Immunol.  131:1539. 
4.  Welsh,  R.  M.  1981.  Natural cell-mediated immunity during viral infections.  Curr. 
Top. Microbiol. Immunol.  92:83. 
5.  Bancroft, G.J., G. R. Shellam, andJ.  E. Chalmer.  1981. Genetic influences on the 
augmentation of natural killer (NK) cells during murine cytomegalovirus infection: 
correlation with patterns of resistance. J. Immunol.  126:988. 
6.  Shellam, G. R., J. E. Allen, J. M. Papadimitriou, and G. J. Bancroft. 1981. Increased 
susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. 
USA.  78:5104. 
7.  Boos, J., and E.  F.  Wheelock.  1971. Correlation of survival from MCMV infection 
with spleen cell responsiveness to concanavalin A. Proc. Soc. Exp. Biol. Med.  149:443. 
8.  Henson,  D.,  R.  D.  Smith, and J.  Gehrke.  1966.  Non-fatal mouse cytomegalovirus 
hepatitis.  Combined morphologic, virologic, and immunologic observations. Am. J. 
Pathol.  49:871. 
9.  Quinnan,  G.  V., Jr., J.  E.  Manischewitz,  and  N.  Kirmani.  1982.  Involvement of 
natural  killer cells in the pathogenesis of murine cytomegalovirus interstitial pneu- 
monitis and the immune response to infection. J. Gen.  Virol.  58:173. 
10.  Bukowski,J. F., B. A. Woda, S. Habu, K. Okumura, and R. M. Welsh. 1983. Natural 
killer cell depletion  enhances virus synthesis and virus-induced hepatitis in  vivo. J. 
Immunol.  131:1531. 
11.  Bukowski, J.  F.,  B.  A.  Woda,  and  R.  M.  Welsh.  1984.  Pathogenesis  of murine 
cytomegalovirus infection in natural killer cell-depleted mice. J. Virol.  52:119. 
12.  Ebihara,  K.,  and  Y.  Minamishima.  1984.  Protective  effect of biological  response 
modifiers on murine cytomegalovirus infection. J. Virol.  51 : 117. 
13.  Vassalli, J.-D., A. Granelli-Piperno, C. Griscelli, and E. Reich. 1978. Specific protease 
deficiency in polymorphonuclear leukocytes of Ch~diak-Hagashi syndrome and beige 
mice.J. Exp. Med.  147:1285. 
14.  Kasai, M., M. Iwamori, Y. Nagai, K. Okumura, and T. Tada.  1980. A glycolipid on 
the surface of mouse natural killer cells. Eur. J. Immunol.  10:175. 
15.  Habu,  S.,  H.  Fukui,  K.  Shimamura,  M.  Kasai,  Y.  Nagai,  K.  Okumura,  and  N. 
Tamaoki.  1981.  In  vivo  effects of anti-asialo GM1.  Reduction  of NK activity and 
enhancement of transplanted tumor growth in nude mice. J. Immunol.  127:34. 52  NATURAL  KILLER CELLS MEDIATE ANTIVIRAL EFFECTS IN  VIVO 
16.  Welsh,  R. M., and R. W. Kiessling.  1980. Natural killer cell response to lymphocytic 
choriomeningitis virus in beige mice. Scand. J. Immunol.  I 1:367. 
17.  Selgrade, M. K., andJ. E. Osborn. 1974. Role of macrophages in resistance to murine 
cytomegalovirus. Infect.  Immun.  10:1383. 
18.  Nedrud, J. G., A. M. Collier,  and J. S.  Pagano.  1979.  Cellular basis of susceptibility 
to  murine  cytomegalovirus: evidence  from  tracheal  organ  culture. J.  Gen.  Virol. 
45:737. 
19.  Kiessling, R., E. Eriksson,  L. A. Hallenbeck, and R. M. Welsh.  1980.  A comparative 
analysis of the cell surface properties of activated vs. endogenous mouse natural killer 
cells. J. lmmunol.  125:1551. 
20.  Kawase,  I., D. L. Urdal, C. G. Brooks, and C. S. Henney.  1982.  Selective  depletion 
of NK  cell  activity in  vivo  and  its  effect on the  growth of NK  sensitive  and  NK 
resistant tumor cell variants. Int. J. Cancer.  29:567. 
21.  Davignon,  D.,  E.  Martz,  T.  Reynolds,  K.  Kurzinger,  and  T.  A.  Springer.  1981. 
Lymphocyte function-associated antigen  1 (LFA-1): a surface antigen distinct from 
Ly-2, 3 that participates in T lymphocyte-mediated killing. Proc. Natl. Acad. Sci. USA. 
78:4535. 
22.  Burton, R. C.  1980. Alloantigens selectively  reactive with NK cells: characterization 
and  use  in  defining NK cell  classes. In:  Natural  Cell  Mediated  Immunity Against 
Tumors. R. B. Herberman, editor. Academic Press,  Inc., New York.  19-23. 
23.  Dennert, G.  1980. Cloned lines of natural killer cells. Nature (Lond.) 237:47. 
24.  Baker, P.  E., S. Gillis, and K. A. Smith.  1979.  Monoclonal cytotoxic T-cell lines. J. 
Exp. Med.  149:273. 
25.  Kumagai, K., K. Itoh, R. Suzuki, S. Hinuma, and F. Saitoh.  1982. Studies of murine 
large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxic- 
ities.J. Immunol.  129:388. 
26.  Welsh,  R. M.  1984. Interferon and natural killer cells. CRC Crit.  Rev. Immunol.  5:55. 
27.  Ho,  M.  1980.  Role of specific  cytotoxic lymphocytes in  cellular immunity against 
murine cytomegalovirus. Infect. Immun.  27:767. 
28.  Araullo-Cruz, T.,  M.  Ho.,  and J.  A.  Armstrong.  1978.  Protective effect of early 
serum from mice after cytomegalovirus infection. Infect.  lmmun.  21:840. 
29.  Warner, J. F., and G. Dennert.  1982.  Effects of a cloned cell line with NK activity on 
bone  marrow  transplants,  tumour  development,  and  metastases  in  vivo.  Nature 
(Lond.). 300:31. 
30.  Lopez,  C.  1981.  Resistance  to  herpes  simplex  virus  type  I  (HSV-1).  Curr.  Top. 
Microbiol.  Immunol.  92:15. 
31.  Tardieu,  M.,  C.  Hery,  and J.  M.  Dupuy.  1980.  Neonatal  susceptibility  to  MHV 
infection in mice.  II. Role of natural effector marrow cells in transfer of resistance. 
J. Immunol.  124:418. 
32.  Kumar, V., and M. Bennett.  1981.  Genetic resistance to Friend virus-induced eryth- 
roleukemia and immunosuppression. Curr.  Top. Microbiol.  lmmunol., 92:65. 
33.  Minato, N., B. R. Bloom, C. Jones, J. Holland, and L. M. Reid.  1979.  Mechanism of 
rejection of virus persistently infected tumor cells by athymic nude mice. J. Exp. Med. 
149:1117. 
34.  Hirsch, R. L.  1981.  Natural killer cells appear to play no role in the recovery of mice 
from Sindbis virus infection. Immunology. 43:81. 